JIPOAd
JIPOAd
PARP
ESID
  • Users Online: 309
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2019| October-December  | Volume 2 | Issue 4  
    Online since November 11, 2019

 
 
  Archives   Previous Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
ORIGINAL RESEARCH
Haplotype Analysis of the T-Cell Receptor Beta (TCRB) Locus by Long-amplicon TCRB Repertoire Sequencing
Timothy J Looney, Dzifa Y Duose, Geoffrey Lowman, Elizabeth Linch, Joud Hajjar, Denise Topacio-Hall, Mingxuan Xu, Jianping Zheng, Anas Alshawa, Coya Tapia, Bettzy Stephen, Linghua Wang, Funda Meric-Bernstam, Lauren Miller, Alexander Glavin, Lifeng Lin, Jing Gong, Jeffrey Conroy, Carl Morrison, Fiona Hyland, Aung Naing
October-December 2019, 2(4):137-143
DOI:10.4103/JIPO.JIPO_16_19  
  1,224 56 -
CASE REPORT
MET receptor amplification drives resistance to Anti-EGFR therapies
Patricia Martin Romano, Eduardo Castanon, Antoine Hollebecque, Ludovic Lacroix, Nathalie Auger, Eric Angevin, Lambros Tselikas, Sami Ammari, Jean-Charles Soria, Christophe Massard
October-December 2019, 2(4):152-155
DOI:10.4103/JIPO.JIPO_7_19  
  1,193 53 -
ORIGINAL RESEARCH
Analysis of Programmed Death-Ligand 1 Expression, Stromal Tumor-Infiltrating Lymphocytes, and Mismatch Repair Deficiency in Invasive Micropapillary Carcinoma of the Breast
Sara Simonetti, Nuria Dominguez, Analia Elguezabal, Francesco Pepe, Mariantonia Nacchio, Floriana Conticelli, Umberto Malapelle, Giancarlo Troncone, Lidia Sanchez, Xavier Guardia, Paolo Nuciforo, Luigi Insabato
October-December 2019, 2(4):130-136
DOI:10.4103/JIPO.JIPO_17_19  
  993 43 -
REVIEW ARTICLE
Review of immunogenomics and the role of tumor mutational burden as a biomarker for immunotherapy response
Javier Ros, Iosune Baraibar, Ana Vivancos, Jordi Rodon
October-December 2019, 2(4):144-151
DOI:10.4103/JIPO.JIPO_19_19  
  794 33 -
LETTERS TO THE EDITOR
In the era of immune checkpoint inhibitor therapy, can we safely expand to patients with immunodeficiency?
Mehmet Asim Bilen, Razelle Kurzrock
October-December 2019, 2(4):129-129
DOI:10.4103/JIPO.JIPO_20_19  
  544 34 -
Cancer immunotherapy in the immunosuppressed patients and its relevance to clinical practice
Vaia Florou, Ignacio Garrido-Laguna
October-December 2019, 2(4):127-128
DOI:10.4103/JIPO.JIPO_18_19  
  494 45 -
CONFERENCE PROCEEDINGS
Meeting Proceedings of the “Phase I: Where Science Becomes Medicine” Conference, Manchester, UK: Meeting Overview
Donna M Graham, Louise Carter, Matthew G Krebs, Duncan Jodrell, Anne Armstrong, Elaine Kilgour, Tim Illidge, Joseph Clarke, Rachel Chown, Kaye Williams, Caroline Dive, Janelle Yorke, Clare Dickinson, Andrew Hughes, Fiona Thistlethwaite, Rob Bristow, Natalie Cook
October-December 2019, 2(4):156-174
DOI:10.4103/2666-2345.269514  
  233 20 -
ACKNOWLEDGMENTS
Guest Editor and Reviewer Acknowledgments

October-December 2019, 2(4):175-175
DOI:10.4103/2666-2345.270653  
  72 12 -